2084.5000 -77.70 (-3.59%)
NSE Aug 26, 2025 15:31 PM
Volume: 98,702
 

2084.50
-3.59%
Caplin Point Laboratories maintains export momentum, expands ambitions to new markets
By Ketan Sonalkar

 

Caplin Point Laboratories is an export-oriented pharmaceutical company that generates its entire revenues through exports. The majority of its revenues comes from the less regulated markets of Latin America, where it has established a strong presence over the last two decades. In recent years, the company has also entered the US market and is planning on expanding its presence there. …

Premium This is a premium article. Click here to read.

Caplin Point Laboratories Ltd. is trading below its 30 day SMA of 2090.7
More from Caplin Point Laboratories Ltd.
More from Ketan Sonalkar
Recommended